CompletedPhase 4NCT03384277

Trial of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab

Studying Acquired hemophilia A

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Principal Investigator
Lei Zhang, MD
Blood disease hospital, Chinese academy of medical sciences
Intervention
Steroid(drug)
Enrollment
66 enrolled
Eligibility
18-80 years · All sexes
Timeline
2017 – 2022

Study locations (1)

Collaborators

Qilu Hospital of Shandong University · Tianjin First Central Hospital · The Second Affiliated Hospital of Kunming Medical University · Henan Cancer Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03384277 on ClinicalTrials.gov

Other trials for Acquired hemophilia A

Additional recruiting or active studies for the same condition.

See all trials for Acquired hemophilia A →

← Back to all trials